MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    The effect of subthalamic deep brain stimulation on response inhibition and voluntary action control depend on connectivity of the volume of activated tissue with the prefrontal cortex

    J. Waldthaler, A. Sperlich, C. Stüssel, K. Steidel, L. Timmermann, D. Pedrosa (Marburg, Germany)

    Objective: The effect of subthalamic deep brain stimulation on response inhibition and voluntary action control depend on connectivity of the volume of activated tissue with…
  • 2023 International Congress

    Premenstrual worsening of UPDRS motor scale in women affected by Parkinson’s Disease

    A. Thomas, D. Calisi, M. de Rosa, P. Ajdinaj, S. Sensi, M. Onodrj (Chieti, Italy)

    Objective: The role of estrogen in dopaminergic pathways and the premenstrual worsening of parkinsonian symptoms. Background: Female sex hormones, during the menstrual cycle, could influence…
  • 2023 International Congress

    Elevated plasma CREG1 levels are linked to a lower risk of Parkinson’s disease

    X. Guo, R. Zhou, G. Tian, R. Li (Xi'an, China)

    Objective: The purpose of this study is to assess the causal associations between plasma cellular repressor of E1A-stimulated genes 1 (CREG1) levels and the risk…
  • 2023 International Congress

    Brain MRI volumetry analysis for patients with Parkinson’s disease suffering from REM sleep behavior disorder: a pilot study

    T. Vanagas, G. Paulekiene, A. Radziunas, R. Balnyte, E. Pajediene, E. Paulekas (Kaunas, Lithuania)

    Objective: To detect patients with Parkinson's disease that have REM sleep behavior disorder (RBD) and perform brain MRI volumetry analysis. Background: Parkinson’s disease is classically…
  • 2023 International Congress

    Explainable deep learning based detection of Parkinson’s changes in MRI brain scans

    M. Courtman, M. Thurston, L. Mcgavin, C. Carroll, L. Sun, E. Ifeachor, S. Mullin (Plymouth, United Kingdom)

    Objective: A pilot study using an AI-based framework to classify routine brain scans as Parkinson’s disease (PD) or control. Background: Prospective neuroprotective treatments for PD…
  • 2023 International Congress

    Metabolic modulation of mitochondrial DNA release in cellular models of Parkin-associated Parkinson’s disease

    G. Agyeah, P. Antony, K. Wasner, A. Rakovic, S. Pereira, A. Grünewald (Esch-Sur-Alzette, Luxembourg)

    Objective: Our objective in this study was to elucidate the mechanisms underlying the release of mtDNA in cellular models of Parkin-associated Parkinson’s disease and to…
  • 2023 International Congress

    Safety in Levodopa/carbidopa Intestinal Gel (LCGI) titration in the Intensive Care Unit (ICU) setting for Parkinson’s Disease (PD) patient with severe dysphagia

    N. Lopez Ariztegui, G. Tabar Comellas, MI. Morales Casado, D. Rivero Rodriguez, M. Ennazeh, P. Leal Sanz (Toledo, Spain)

    Objective: Describe a PD patient with obsessive-compulsive disorder (OCD) and paranoid symptoms in whom treatment with LCIG was started in the ICU due to severe…
  • 2023 International Congress

    Parkinson’s disease and human gut microbiota in an Egyptian population: a pilot study

    S. Hashish, M. Hirose, A. Moustafa, A. Shalash, S. Ibrahim, M. Salama (Cairo, Egypt)

    Objective: The main objective of our research is to decipher the association between the gut microbiota and Parkinson's disease in an Egyptian cohort. Background: Parkinson’s…
  • 2023 International Congress

    Focused ultrasound as rescue treatment of essential tremor after deep brain stimulation.

    D. Vilas, M. Tardáguila, L. Ispierto, J. Muñoz, M. Gea, A. Gonzalez, S. Jaume, G. Plans, R. Alvarez (Badalona, Spain)

    Objective: To describe a case of disabling essential tremor (ET) treated with unilateral MRI-Guided Focused Ultrasound (FUS) thalamotomy as rescue treatment after deep brain stimulation…
  • 2023 International Congress

    Cognition evaluation in patients following focused ultrasound thalamotomy for tremor

    I. Shifrin Senderova, I. Schlesinger, M. Nassar, A. Sinai, R. Haddad, I. Erikh, L. Shornikov, M. Constantinescu (Haifa, Israel)

    Objective: Evaluation of cognitive function before and following unilateral FUS VIM-thalamotomy in tremor patients. Background: VIM focused ultrasound (FUS) thalamotomy has established efficacy in tremor…
  • « Previous Page
  • 1
  • …
  • 224
  • 225
  • 226
  • 227
  • 228
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25128 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley